Back to Results

REMSleep Holdings Inc (RMSL)

REMSleep Holdings Inc is a healthcare company focused on medical technology for sleep apnea. Through its common stock listed on OTC Markets, the company develops and distributes products designed to support people living with sleep apnea globally. Its product line includes the DeltaWave CPAP interface device, which is intended for use in sleep apnea treatment. REMSleep serves a range of customers and channels, including sleep product distributors, home care dealers, private sleep labs, end users, sleep physicians, medical groups, hospitals, and medical associations. The company is headquartered in Clearwater, Florida.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-RMSL
$0.00080
-92.0% Downside
Expensive
Not available
Not available
Weak
0.0%
206.7x
2.513 M
2.626 M
0.9%
99.4%
-207.1
22.0%
Valuation • Fair Value

REMSleep Holdings Inc (OTC-RMSL) Fair Value by Valuation Model

Review the available estimates for REMSleep Holdings Inc (OTC-RMSL), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.00080

Estimated downside of 92.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.00080

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for REMSleep Holdings Inc (OTC-RMSL) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for REMSleep Holdings Inc (OTC-RMSL)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

11.897 K

Current operating scale indicator.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-2.736 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review REMSleep Holdings Inc (OTC-RMSL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for REMSleep Holdings Inc (OTC-RMSL)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-207.1

Lower score that deserves closer risk review.

FCF / Net Income

22.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for REMSleep Holdings Inc (OTC-RMSL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for REMSleep Holdings Inc (OTC-RMSL)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for REMSleep Holdings Inc (OTC-RMSL). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for REMSleep Holdings Inc (OTC-RMSL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for REMSleep Holdings Inc (OTC-RMSL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for REMSleep Holdings Inc (OTC-RMSL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for REMSleep Holdings Inc (OTC-RMSL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for REMSleep Holdings Inc (OTC-RMSL) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

REMSleep Holdings Inc (OTC-RMSL) Stock FAQ

Data-supported answers about REMSleep Holdings Inc (OTC-RMSL), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.00080
Estimated downside 92.0%
Valuation Rating
Overvalued
Estimated downside of 92.0%
Financial Health
Weak
Current financial-health read

The current fair value estimate for REMSleep Holdings Inc (OTC-RMSL) is $0.00080. This implies an estimated downside of 92.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 92.0% versus the current market price.

The current financial health read for REMSleep Holdings Inc (OTC-RMSL) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for REMSleep Holdings Inc (OTC-RMSL).

The current market capitalization listed for REMSleep Holdings Inc is 2.513 M.

The current enterprise value listed for REMSleep Holdings Inc is 2.626 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for REMSleep Holdings Inc is OTC-RMSL, and the stock is listed on OTC Markets.

REMSleep Holdings Inc (OTC-RMSL) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for REMSleep Holdings Inc is 0.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for REMSleep Holdings Inc is 99.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B